Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 15, 2025Neuro-Oncology Practice

Neoadjuvant Stereotactic Radiosurgery for Brain Metastases: A Systematic Review and Meta-Analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

BHBardia HajikarimlooMHMohammad Amin HabibiIMIbrahim Mohammadzadeh

Discussion

Loading...

Member takes

Overview

Systematic review shows neoadjuvant stereotactic radiosurgery improves local control in brain metastasis, suggesting low toxicity.

Key Points

  • Neoadjuvant stereotactic radiosurgery significantly improves local control rates at 12 months, reaching 91%.
  • Pooled distant brain failure rates were 35% at 12 months, indicating notable concerns in management.
  • Systematic review included ten studies assessing key outcomes in 791 patients, showcasing the efficacy of neoadjuvant therapy.
  • Neoadjuvant SRS may offer beneficial results compared to traditional methods, calling for further randomized trials.

Cite This Study

Hajikarimloo et al. (2025) studied this question.

synapsesocial.com/papers/68a365600a429f797332b709https://doi.org/10.1093/nop/npaf086
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Neoadjuvant stereotactic radiosurgery for brain metastases: Current evidence and clinical perspectives.2025 · 2 citations
  2. 2Neoadjuvant Stereotactic Radiotherapy for Brain Metastases2025 · 1 citations
  3. 3Neoadjuvant fractionated stereotactic radiotherapy followed by surgical resection for brain metastases: A multicenter, single arm phase II trial (NEO-TACTICS).2026
  4. 4Outcomes after single-fraction preoperative stereotactic radiosurgery for brain metastases: A systematic review and meta-analysis.2026
  5. 5Safety and Feasibility of Stereotactic Radiosurgery for Patients with 15 or more Brain Metastases2024 · 12 citations